Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
hope this slow bleed wasnt insiders slow dumping bc they knew somthing was coming
Cant find any news on halted hope its good
THE SCHOOL IS HEADED TO $DMAN closed up yesterday .0040 should continue today MONO tweeting about his SSTARTER position yesterday
23 on BreakoutOut Boards ITS coming
I call it the fish school when a pinky gets hot and lots of chatter the traders tear it up like piranhas which is the case here, seeing, hearing lots
The school is coming back around to feed nice tweets last time we went what to .02...Ill pick up more at the open for sure
Very Nice day! its coming
Damn penneys back is the old gang getting back together for a tour?
Let DEEPBARRY Turn the lights off since he had over 100g's in this this scam They should be sued and jailed
SUSPENSION About time this has gone on long enough on the backs of good peeps
http://www.kading.co/About-Us.html
Looking for gold to rebound in big way already starting
Kading Companies S.A. is a project development & asset management company focused on the mining and metals industry with an emphasis on precious metals, base metals and rare earth’s. Our focus is on Latin America and currently targeting gold and silver in Peru, and copper in Chile.
In order to achieve optimal returns on capital deployed into various mining and metals assets, we are utilizing a traditional project development business-revenue model, investment structure and execution plan for all Assets Under Management (AUM). As a part of this model, we apply proven “tolling structures”, “bankable” transactional framework along with structured project finance non-recourse and limited-recourse financing to create an appreciable return for our investors.
Being a strategic alliance partner, we will specifically target opportunities which require asset monetization and commoditization along the entire mining and metals value chain. The process of monetization and commoditization covers: Mining; Processing; Refining; Market Aggregation/Consolidation and; Export/Trading. Due to the increase in precious metals (gold, silver etc.) production in South America, we plan on targeting mines ranging from existing producing assets, to those nearing commercial operations as well as projects in advanced development stages.
Kading Companies risk mitigated approach involves being directly involved as a strategic alliance partner with a focus on all project development activities, deployment of “secured” capital via our structured finance plan (non-recourse, limited-recourse) with transactional framework arrangements along the entire mining and metals value chain. With this approach we are confident we can create value for our investors.
Who ever dumped this morning and gave me
those .0025's after being in the 30's THANKS
Very Nice Great Post....
ABOUT time this came back into play been waiting along time like most here
$HIHI 7'S Gone 8's up and thin....
No bid sitting you just lost 7's lets get 8's who ever got that 855966 nice job
Ok I JUST GRABBED 2 mil someone get that last bit lets get it moving
Your like myself most of what I REALIZE in profits come here and you know the other....this one is MONEY jury's still out on other until the sales come in! THANKS
Git while the gittin's GOOD! not skeerd to avg down!, more skeerd to loose this opportunity...But thks anyway
OK I'll take another 2000 down here @ 4.02
Good confident post love it picked up 24,000 more today buying the Dips Bro
HUNCH Thanks for heads up, out all day missed todays action..trying to play catch up...
OUTSTANDING hippd is ok.
Another way to pick more ARGRA shares would be simply buy
QILFF Which is now trading @ .267
(SEE HUNCHBACKGEEKS) POST 289
It is anticipated that the sale price for the assets will be comprised of 1.15 shares of Agraflora for each one (1) issued and outstanding share of OFIG at the time of closing (the “Consideration Shares”), with the Consideration Shares to be distributed to the shareholders of OFIG. Closing of the Proposed Transaction remains subject to applicable corporate, securities and exchange approvals and/or filings, as the case may be.
30,000 x 1.15 is 34500 a gain of 4500 shares I Didnt see any restrictions as to when or how long u were to hold OR BE IN QILFF
for some with limited funds or simply just want extra shares
and who doesn't great way to do it kind of the back door route..
anybody know if Hippd is still alive after that .35 buy?
while we have alittle time this is cool
https://www.trade-ideas.com/ticky/ticky.html?symbol=PUFXF
Getting time to load up again!
hardly wait HUNCH! and when all is done at DELTA B.C.
'this to will cut"
Oils in OCT you are correct are going to be huge thats why I'am in a few of the extraction companys as well.....
Saw that Hunch, got a pretty good core .22 and under fishing for cheapies....Thanks for all you do!
Thats where I'am at.
Nice grab a/h on AVP quick flip
Love ya, Thanks for all you bring to this board...wouldnt be the same without you and a few others.
excluding the Formulation this is what concerns me and what I Would look for the COMPANY. ANY IDEAS
Wonder who the company will be that manufacturers the treatment be it pill or oils, that what we need to find out
WE just keep pumping out NEWS This is on the way...
How did u know of all their songs this is the one I wore out!
A big Thanks! I NEEDED THAT TODAY
looking more toward these two extraction companys valens and medipharm
MediPharm Labs Secures Cannabis Manufacturing Licence in Australia
WITH oils OCT 16 IN CANADA GOING TO BE HUGE but heres medif pr yesterday
NEWS--TORONTO , May 21, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce that its subsidiary, MediPharm Labs Australia Pty. Ltd. (“MediPharm Labs Australia”), has received its cannabis manufacturing licence (the “Licence”) from the Australian Office of Drug Control under the Narcotics Drugs Act 1967 on May 21, 2019 . This is a significant milestone for MediPharm Labs that establishes the Company as an early mover in the Australian cannabis industry. In addition, MediPharm Labs Australia is expected to provide the Company with a global supply chain platform and a foothold in the Asia-Pacific region .
“MediPharm Labs Australia’s cannabis manufacturing licence marks a significant achievement and important milestone that establishes MediPharm Labs as the largest Canadian extraction-only company with a clear path towards a global supply chain,” said Patrick McCutcheon , CEO, MediPharm Labs . “With this licence, MediPharm Labs Australia provides a foothold in the Asia-Pacific region as we focus on completing construction, and beginning the facility’s GMP certification and remaining licensing requirements which will permit us to commence production and sales later this year.”
“After starting on this journey nearly two years ago, we are extremely pleased to have been awarded a Medicinal Cannabis Manufacturing Licence from the Office of Drug Control ,” said Warren Everitt , Managing Director, MediPharm Labs Australia. “Construction on the facility is well underway and we are one step closer to becoming a leading producer of cannabis concentrates for Australia and the Asia-Pacific region.”
The Licence authorizes MediPharm Labs Australia to the manufacture extracts and tinctures of cannabis and cannabis resin under the Narcotics Drugs Act 1967. Products manufactured under the Licence must be only for the purpose of a clinical trial or prescribed as medicinal cannabis products.
MediPharm Labs Australia continues to work on completing the build of a state of art facility in Wonthaggi, Victoria (132 km south east of Melbourne ), for industrial-scale production supported by leading infrastructure designed with ISO standard-built cleanrooms and critical environments, considering global GMP workflow. The facility will be outfitted with supercritical CO2 extraction capacity to process up to 75,000 kg of dried cannabis annually as well as state-of-the-art secondary processing equipment for the manufacture of purified and high-concentrate cannabis distillate. MediPharm Labs Australia will be permitted to commence production and sales activities upon receipt of its GMP and certain other local licences expected later this year.
About MediPharm Labs Corp.
Founded in 2015, MediPharm Labs has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the ACMPR without first receiving a cannabis cultivation license. This expert focus on cannabis concentrates begins in its purpose-built laboratory designed to incorporate cGMP (current Good Manufacturing Practices) workflow and ISO standard-built clean rooms and critical environments, allowing MediPharm Labs to produce purified, pharmaceutical-like cannabis oil and concentrates for advanced derivative products. MediPharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream extraction methodologies and purpose-built facilities to deliver pure, safe and precisely-dosed cannabis products to patients and consumers. MediPharm Labs’ private label program is a high margin business for the company, whereby it opportunistically procures dry cannabis flower and trim from its numerous product supply partners, to produce cannabis oil concentrate products for resale globally on a private label basis.
For further information, please contact: Laura Lepore , VP, Investor Relations Telephone: 705-719-7425 ext 216 Email: investors@medipharmlabs.com Website: www.medipharmlabs.com
MY THREE TODAY
1. pufxf
2. medif
3 mdcl
all three solid
This is not my work I COPIED AND PASTED HERE. from medicine man board...
$8/share - Hell yea! Pay the CEO!... On May 15, 2019, the Board of Directors (the “Board”) of Medicine Man Technologies (the “Company”) approved an employment agreement entered into between the Company and Andrew Williams, the Company’s CEO dated as of January 25, 2019 (the “Agreement”). Pursuant to the terms and subject to the conditions set forth in the Agreement, Mr. Williams shall receive: (i) $300,000 base salary per annum; (ii) annual bonus determined by the Company determined based on certain considerations including the Company’s stock price and trading volume, overall revenue growth and execution of the Company’s business plan; (iii) 1,000,000 shares of the Company’s common stock if at any point the Company’s common stock appreciates to $8.00 per share.